These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Listed as ongoing, but also has a completion date and reported results 2004-000046-21 A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study Evaluating the Efficacy and Safety of CNTO 148 Administered Subcutaneously in Symptomatic Subje... 2007-07-17 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-000145-38 A Phase 2, Double-blind, Placebo-controlled, Randomized, Dose-ranging Study of Multiple Subcutaneous Injections of Human Monoclonal Antibody to IL-12p40 (CNTO 1275) in Subjects with Relapsing-remittin... 2006-11-03 bad-data
Completed, but no date, and reported results 2004-000326-70 A Randomized, 6-Week Double-Blind, Placebo-Controlled Study With an Optional 24-Week Open-Label Extension to Evaluate the Safety and Tolerability of Flexible Doses of Extended Release OROS® Paliperido... bad-data
Listed as ongoing, but also has a completion date and reported results 2004-000617-19 A Randomized Controlled Study of Docetaxel Monotherapy or Docetaxel and DOXIL for the Treatment of Advanced Breast Cancer 2008-12-18 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-000730-37 A multicentre, randomised, double-blind, placebo-controlled, parallel group, dose-response phase III A study to evaluate safety and efficacy of Prolonged Release (PR) OROS methylphenidate (18, 36 and ... 2006-10-03 bad-data
Completed, but no date, and reported results 2004-000830-35 Maintenance of the clinical response with long-acting injectable Risperidone in patients with Schizophrenia or schizoaffective disorders bad-data
Listed as ongoing, but also has a completion date and reported results 2004-000870-29 CONSTATRE: Risperdal Consta Trial of Relapse prevention and Effectiveness 2007-12-18 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-001178-13 An International Single-Arm Protocol to Provide Expanded Access to VELCADE(TM) for Patients With Multiple Myeloma Who Have Received at Least Two Previous Lines of Therapy and are Refractory to or Have... 2006-06-16 bad-data
Ongoing, reported early 2004-001201-10 Comparison of transdermal fentanyl PCA and IV morphine PCA in the management of post-operative pain control. not-yet-due
Listed as ongoing, but also has a completion date and reported results 2004-001719-77 A Randomized Study of Tipifarnib Versus Best Supportive Care (Including Hydroxyurea) in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) in Subjects 70 Years or older. 2007-10-05 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-001730-17 A Phase 3, Randomized Double-Blind Study of Ceftobiprole Medocaril Versus Linezolid Plus Ceftazidime in the Treatment of Nosocomial Pneumonia 2007-05-29 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-001842-34 A Randomized Controlled Study of DOXIL/CAELYX (doxorubicin HCL liposome injection) and VELCADE (bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma 2014-05-30 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-001989-41 An Open-Label, Randomized Study of VELCADE/Melphalan/Prednisone versus Melphalan/Prednisone in subjects with previously untreated Multiple Myeloma. 2011-04-19 bad-data
Ongoing, reported early 2004-002069-19 A Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy, Safety, and Tolerability of RWJ-333369 as Adjunctive Therapy in Subjects with Refractory Partial Seizures not-yet-due
Listed as ongoing, but also has a completion date and reported results 2004-002130-18 A Phase 1/2 , Multi-Center, Blinded, Randomized, Controlled Study of the Safety and Efficacy of the Human Monoclonal Antibody to Human av Integrins (CNTO 95), Alone and in Combination with Dacarbazine... 2009-02-06 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-002694-22 A Randomized, Double Blind, Parallel-Group Comparative Study of Flexibly Dosed Paliperidone Palmitate(25, 50, 75, 100 mg eq) Administered Every 4 Weeks and Flexibly Dosed Risperdal Consta (25, 37.5, o... 2007-10-24 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-002700-16 A Placebo-Controlled, Double-Blind, Randomized, Parallel-Group Study of the Efficacy and Safety of Dapoxetine in the Treatment of Subjects With Premature Ejaculation 2006-10-17 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-002815-10 Multicenter, Randomized, Double-Blind, Active-Controlled Trial Comparing REMICADE® (infliximab) and REMICADE® plus Azathioprine to Azathioprine in the Treatment of Patients with Crohn’s Disease Naive ... 2009-12-11 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-003295-10 A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNF 945; Monoclonal Antibody, Administered Subcutaneously, in Methotrexatena ve Subjects with Activ... 2012-06-06 bad-data
Reported results 2004-003296-36 A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFalfa Monoclonal Antibody, Administered Subcutaneously, in Subjects with Active Rheumatoid Arthriti... 2012-05-17 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-003298-10 A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFalfa Monoclonal Antibody, Administered Subcutaneously in Subjects with Active Psoriatic Arthritis 2012-01-13 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-003299-12 A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFalfa Monoclonal Antibody, Administered Subcutaneously, in Subjects with Active Ankylosing Spondyli... 2012-01-18 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-003781-14 A Randomized, Double-Blind, Placebo-Controlled Study to Explore the Efficacy and Safety of Risperidone Long-Acting Intramuscular Injectable in the Prevention of Mood Episodes in Bipolar I Disorder, wi... 2008-02-21 bad-data
Reported results 2004-004162-33 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging, Multicenter Study of the Efficacy of RWJ-333369 in the Prophylaxis of Migraine 2006-02-06 due-trials
Reported results 2004-004648-29 A Multicenter, Open-label, Phase 2 Study of VELCADE (bortezomib) for Injection in Previously Treated Patients with Stage IIIB and IV Bronchioloalveolar Carcinoma and Adenocarcinoma with Bronchioloalve... 2008-07-16 due-trials
Reported results 2004-004871-12 An Open-Label Phase 1/2 Study of VELCADE (bortezomib) for Injection in Subjects with Light-Chain (AL)-Amyloidosis 2012-07-21 due-trials
Reported results 2004-005187-24 Randomized, open label, comparative parallel group study to assess efficacy and safety of flexible dosages of OROS hydromorphone once-daily compared to sustained release oxycodone twice-daily in subje... 2008-04-30 due-trials
Listed as ongoing, but also has a completion date 2004-005213-11 A multi-centre, randomised, double-blind, parallel group study assessing the efficacy and safety of IV nesiritide versus placebo, in addition to background care, in the treatment of subjects with acut... 2006-06-01 bad-data
Ongoing, reported early 2005-001234-32 A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Topiramate for the Prophylaxis of Migraine in Pediatric Subjects 12 to 17 Years of Age not-yet-due
Listed as ongoing, but also has a completion date and reported results 2005-001338-33 A Randomized, Double-Blind, Placebo Controlled, Fixed Dose-Ranging Study to Assess the Safety, Tolerability, and Efficacy of Topiramate Oral Liquid and Sprinkle Formulations as an Adjunct to Concurren... 2007-11-05 bad-data
Ongoing, reported early 2005-001339-31 Estudio abierto, aleatorizado, multicéntrico con extensión abierta para evaluar la farmacocinética y seguridad de la solución oral líquida y de la formulación dispersable de topiramato como terapia a... not-yet-due
No trial status on register 2005-001438-34 A Phase II, Randomized, Investigator-Blinded, Parallel-Group, Pilot Study Evaluating the Safety, Palatability and Efficacy of Four Doses of Pancrelipase Microtablets in the Treatment of Infants and To... bad-data
Listed as ongoing, but also has a completion date and reported results 2005-001742-16 A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFalfa Monoclonal Antibody, Administered Subcutaneously in Subjects with Active Rheumatoid Arthritis... 2012-05-22 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-001845-40 A Randomized, Crossover Study to Evaluate the Overall Safety and Tolerability of Paliperidone Palmitate Injected in the Deltoid or Gluteus Muscle in Subjects With Schizophrenia 2007-01-25 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-002301-23 A Phase 3, Randomized, Double-Blind Study Of Ceftobiprole Medocaril Versus Vancomycin With Ceftazidime in The Treatment Of Complicated Skin And Skin Structure Infections 2007-01-31 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-002304-41 Early versus late initiation of treatment with Risperdal Consta in subjects with schizophrenia after an acute episode 2009-12-29 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-002486-36 A randomized, controlled, open-label trial to compare the efficacy, safety and tolerability of TMC114/ritonavir versus lopinavir/ritonavir in treatment-naïve HIV-1 infected subjects. 2012-05-08 bad-data
Ongoing, reported early 2005-002979-33 Estudio de la eficacia y seguridad de risperidona en el tratamiento de adolescentes con esquizofrenia: Estudio abierto de seis meses. not-yet-due
Reported results 2005-003232-21 A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFalfa Monoclonal Antibody, Administered Intravenously, in Subjects with Active Rheumatoid Arthritis... 2009-09-26 due-trials
Reported results 2005-003357-27 A Randomized, Multicenter, Open-Label, Study of Alimta® (pemetrexed) plus VELCADE® (bortezomib) or Alimta Alone or VELCADE alone in Subjects with Locally Advanced or Metastatic Non-Small Cell Lung Can... 2008-01-01 due-trials
Reported results 2005-003525-92 A Phase 2, Multicenter, Randomized, Double-blind, Placebo controlled Trial of CNTO 1275, a Fully Human Anti IL 12 Monoclonal Antibody, Administered Subcutaneously, in Subjects with Active Psoriatic Ar... 2007-12-20 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-003530-17 A Phase 3, Multicenter, Randomized, Double-blind, Placebo controlled Trial Evaluating the Efficacy and Safety of CNTO 1275 in the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis 2011-10-07 bad-data
Completed, reported early 2005-003843-30 Bortezomib and Bendamustine in the Treatment of Refractory/Relapsed Multiple Myeloma 2006-08-14 not-yet-due
Completed, but no date, and reported results 2005-003902-27 Clinical trial on induction of remission with bortezomib (Vel), cyclophosphamide (C) and dexamethasone (D) in patients until the age of 60 with untreated multiple myeloma and planned high dosage chemo... bad-data
Reported results 2005-003949-14 Pilot study of bortezomib under rituximab standard therapy in patients with relapsed or refractory follicular lymphoma and at least 2 prior therapies 2008-12-01 due-trials
Reported results 2005-004037-18 An Open Label, Multicenter Study to Evaluate the Long Term Safety of Prolonged Release (PR) OROS Methylphenidate (18, 36, 54, 72 and 90 mg/day) in Adults with Attention Deficit/Hyperactivity Disorder 2008-07-10 due-trials
Other 2005-004087-24 Global assessment of treatment with IONSYS and its handling by patients, doctors and nursing staff in the management of acute moderate to severe post-surgery pain in hospitalised patients. 2008-09-28 not-yet-due
Ongoing, reported early 2005-004174-24 A Phase 3 Randomized, Double-Blind Study of Ceftobiprole Medocaril versus Linezolid Plus Ceftazidime in the Treatment of Nosocomial Pneumonia not-yet-due
Ongoing, reported early 2005-004383-23 Pragmatic randomized trial of Risperdal Consta versus oral atypical antipsychotics in poorly aderant subjects with schizophrenia ina routine care setting. Protocol RISSCH4055; Phase IV (risperidone m... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2005-004621-25 Is premorbid functioning a predictor of outcome in patients with early onset psychosis treated with Risperdal Consta 2008-03-14 bad-data
Ongoing 2005-004624-38 A Phase II, Multicentre, Randomised, Open-Label, Parallel Group Study to Evaluate the Safety and Efficacy of Velcade® added to Thalidomide-Dexamethasone Standard Treatment in Subjects with Multiple My... not-yet-due
Reported results 2005-004947-73 Bortezomib as consolidation therapy in patients aged 61-75 years with multiple myeloma 2013-05-24 due-trials
Reported results 2005-004948-31 Bortezomib as consolidation therapy in patients aged 60 years and younger with multiple myeloma 2013-05-23 due-trials
Completed, reported early 2005-005343-26 Open-Label Study to Evaluate the Safety and Pharmacokinetics of Single-and Multiple-Dose Extended-Release OROS Paliperidone in Pediatric Subjects (>/= 10 to </= 17 Years of Age) with Schizophrenia, Sc... 2006-10-06 not-yet-due
Reported results 2005-005345-19 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Flexibly-Dosed Extended-Release Paliperidone as Adjunctive Therapy to Mood Stab... 2007-10-01 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-005777-30 A Randomized, Open-Label, Multicenter Study of VELCADE with Rituximab or Rituximab Alone in Subjects with Relapsed or Refractory, Rituximab Naive or Sensitive Follicular B-cell Non Hodgkin's Lymphoma 2010-06-25 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-005812-25 A Randomized, Double-Blind, Active- and Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Flexibly-Dosed Extended-Release Paliperidone Compared with Flexibly... 2007-11-16 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-005819-26 A Phase II, Open-Label Trial Using VELCADE for Re-Treatment of Multiple Myeloma Subjects Following an Initial Response to VELCADE 2010-02-02 bad-data
Reported results 2005-006111-47 A double-blind, randomised, parallel group pilot study to compare macrogol 3350 + electrolytes versus placebo in the overnight relief of constipation 2006-07-10 due-trials
Reported results 2006-000410-20 A Phase 3, Randomized, Open-label, Parallel-group, Multicenter 2010-06-24 due-trials
Reported results 2006-000835-84 Randomized, Double-Blind, Multicenter Study of Ceftobiprole Medocaril Versus Ceftriaxone with/without Linezolid in Treatment of Subjects Hospitalized With Community-Acquired Pneumonia 2007-07-19 due-trials
Completed, but no date, and reported results 2006-000846-38 A Randomized, Double-Blind, Active- and Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Extended-Release Paliperidone as Maintenance Treatment After an Acu... bad-data
Listed as ongoing, but also has a completion date and reported results 2006-000914-19 A randomized, open-label, multicenter study evaluating thrombovascular events in subjects with cancer receiving chemotherapy and administered epoetin alfa once or three times a week for the treatment ... 2009-07-30 bad-data
Ongoing, reported early 2006-001475-38 A DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMIZED, SEQUENTIAL GROUP, MULTIPLE DOSE STUDY OF THE EFFICACY OF THE CRF1-RECEPTOR ANTAGONIST R317573 ON CCK-4 INDUCED ANXIETY IN HEALTHY MALE SUBJECTS. not-yet-due
Reported results 2006-001490-15 A randomized, double-blind, placebo- and active-controlled, parallel-group study to evaluate the efficacy and safety of risperidone long-acting injectable for the prevention of mood episodes in the tr... 2009-04-13 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-001671-38 A Phase 2 Multicenter, Open-label Study of CNTO 328 (Anti-IL-6 Monoclonal Antibody) in Combination with Mitoxantrone versus Mitoxantrone in Subjects with Metastatic Hormone-Refractory Prostate Cancer ... 2008-10-30 bad-data
Reported results 2006-001709-27 A Phase 2, Multicentre, Randomised, Open-Label, Parallel Group Study to Evaluate the Safety and Efficacy of Velcade® when added to Adriamycin-Dexamethasone Treatment versus Vincristine-Adriamycin-Dexa... 2008-02-28 due-trials
Reported results 2006-001897-26 A Phase 2 Multicenter Study of CNTO 328 (Anti Interleukin 6 Monoclonal Antibody) in Subjects with Relapsed or Refractory Multiple Myeloma 2010-03-03 due-trials
Listed as ongoing, but also has a completion date 2006-001904-36 A Phase 2, Randomized, Double-blind, Placebo-controlled Study Comparing the Combination of CNTO 328 (Anti-IL-6 Monoclonal Antibody) and Velcade® versus Velcade alone in Subjects with Relapsed or Refra... 2013-09-02 bad-data
Completed, but no date, and reported results 2006-002499-16 Early Access of TMC125 in combination with other antiretrovirals in treatment-experienced HIV-1 infected subjects with limited treatment options. bad-data
Completed, but no date, and reported results 2006-003278-93 Randomized, Double-Blind, Active-Control, Parallel Group, 90-Day Safety Study of CG5503 Immediate Release or Oxycodone Immediate Release in Subjects With Chronic Pain from Low Back Pain or Osteoarthri... bad-data
Completed, but no date 2006-003359-19 An open-label study of two single oral doses of galantamine, examining the pharmacokinetics, safety, and tolerability in children with Down syndrome bad-data
Listed as ongoing, but also has a completion date and reported results 2006-003397-94 A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects with Moderately ... 2009-01-30 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-003398-28 A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects with Moderately... 2010-11-29 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-003399-37 A Phase 3 Multicenter, Randomized, Placebo-controlled, Double blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects with Moderately... 2015-02-12 bad-data
Ongoing, reported early 2006-003431-78 A Multicenter, Observational Study of the Long-term Safety of Infliximab (REMICADE®) in Subjects with Moderate to Severe Chronic Obstructive Pulmonary disease (COPD) not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-003444-30 A Phase 3, Multicenter, Randomized Study Comparing CNTO 1275 and Etanercept for the Treatment of Moderate to Severe Plaque Psoriasis 2009-01-15 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-003482-14 A One-Year, Randomized, Open-Label, Parallel-Arm, Phase III Long-Term Safety Trial, with Controlled Adjustment of Dose, of Multiple Doses of CG5503 PR and Oxycodone CR in Subjects with Chronic Pain 2008-07-28 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-003560-62 A Randomized, Double-Blind, Parallel-Group, Comparative Study of Flexible Doses of Paliperidone Palmitate and Flexible Doses of Risperidone Long-Acting Intramuscular Injection in Subjects with Schizop... 2009-07-01 bad-data
Reported results 2006-003659-19 A Double Blind, Placebo- and Active-Controlled, Randomized, Sequential Group, Multiple Dose Study to Examine the Effect of the CRF1-Receptor Antagonist R317573 on 7.5% CO2-Inhalation Induced Anxiety i... 2007-02-02 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-003839-68 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RWJ-333369 as Adjunctive Therapy in Subjects with Partial Onset S... 2010-11-05 bad-data
Ongoing, reported early 2006-003941-17 A randomized,double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the efficacy, safety and tolerability of RWJ333369 as adjunctive therapy in subjects with partial onset se... not-yet-due
Reported results 2006-003983-73 A Phase IIa Multicenter, Randomized, Double-Blind, Placebo -Controlled, Parallel Group Study of RWJ-445380 Cathepsin-S Inhibitor in Patients with Active Rheumatoid Arthritis Despite Methotrexate Thera... 2008-03-10 due-trials
Reported results 2006-004015-21 Randomized Clinical Study Comparing Compeed Cold Sore Patch to Zovirax Cream 5% in the Treatment of Herpes Labialis 2007-03-15 due-trials
Ongoing 2006-004265-34 An Open-label Prospective Trial to Explore the Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Subjects With Schizophrenia not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-004513-18 A Randomized, Double-Blind, Active- and Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Multiple Doses of CG5503 Immediate Release Formulation in the Treat... 2007-12-22 bad-data
Reported results 2006-004514-40 A Randomized, Double-Blind, Active- And Placebo-Controlled, Parallel Group, Multicenter Study To Evaluate The Efficacy And Safety of Multiple Doses of CG5503 Immediate Release Formulation In Subjects ... 2007-08-22 due-trials
Ongoing, reported early 2006-005734-20 A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Flexible Dose Paliperidone ER in the Treatment of Subjects with Schizoaffective Disorder not-yet-due
Reported results 2006-005766-39 A Randomized, Double-blind, Multicenter, Phase 2 Study of a Human Monoclonal Antibody to Human aV Integrins (CNTO 95) in Combination With Docetaxel and Prednisone for the First-Line Treatment of Subje... 2010-02-02 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-006050-10 A Phase 2, Randomized Study of VELCADE (bortezomib), Dexamethasone and Thalidomide versus VELCADE (bortezomib), Dexamethasone, Thalidomide and Cyclophosphamide in Subjects with Previously Untreated Mu... 2013-10-04 bad-data
Reported results 2006-006434-17 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose Response Study to Evaluate the Efficacy and Safety of 3 Fixed Doses (25 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmita... 2008-03-24 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-006437-40 A randomised, controlled, opel-label trial to compare the efficacy, safety and tolerability of a treatment simplification by darunavir/ritonavir (DRV/r) 800/100 mg O.D. versus a triple combination the... 2011-01-13 bad-data
Ongoing, reported early 2006-006513-33 A double-blind, randomized, parallel group comparison of Nizoral® cream (F012), ketoconazole 2% cream (F126) and placebo (F000) in the treatment of interdigital Tinea Pedis. not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-006642-34 Tolerability, Safety and Treatment Response of Flexible Doses of Paliperidone ER acutely exacerbated subjects with schizofrenia 2009-05-12 bad-data
Ongoing, reported early 2006-006755-12 An Expanded Access Open Label Study of CB7630 (Abiraterone Acetate) in Patients with Advanced Prostate Cancer Who Have Completed CB7630 Clinical Study COU-AA-001 not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-006772-38 A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Dose Ranging Study to Investigate the Safety and Efficacy of JNJ-16269110 in Overweight and Obese Subjects 2008-06-30 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-006911-60 Randomised, double-blind, placebo-controlled, parallel-group trial to investigate the analgesic effect of OROS hydromorphone hydrochloride in comparison with placebo in subjects with moderate to sever... 2008-11-24 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-006967-22 A Prospective Randomized Open-label 6-Month Head-To-Head Trial to Compare Metabolic Effects of Paliperidone ER and Olanzapine in Subjects with Schizophrenia 2009-04-07 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-000031-26 A 12-Week, Double-Blind, Randomized, Placebo-Controlled Study in Type 2 Diabetes Mellitus Subjects to Evaluate the Efficacy, Safety and Tolerability of MTP Inhibitor JNJ-16269110 2008-09-12 bad-data
Ongoing, reported early 2007-000280-17 An Open Label Single and Repeat Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-17299425 in Patients with Traumatic Brain Injury. not-yet-due
No trial status on register 2007-000576-16 A Randomized, Multicenter, Double-Blind, Weight-Based, Fixed-Dose, bad-data
Listed as ongoing, but also has a completion date and reported results 2007-000577-38 A 2 Year, Open-Label, Single-Arm Safety Study of Flexibly Dosed Paliperidone Extended Release (1.5-12 mg/day) in the Treatment of Adolescents (12 to 17 Years of Age) with Schizophrenia 2013-07-16 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-001117-42 A Randomized, Open-Label, Multicenter Study to Assess the Safety and Tolerability of Doripenem Compared With Imipenem in the Treatment of Subjects With Complicated Intra-Abdominal Infections or Ventil... 2008-11-05 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-001462-33 A Phase 2, Multicentre, Randomised, Open-Label, Parallel Group Study to Evaluate the Safety and Efficacy of VELCADE® in combination with Dexamethasone or VELCADE® in combination with Dexamethasone and... 2011-08-02 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-001670-84 Double-Blind, Placebo-Controlled, Multicenter Acute Study of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure 2011-03-15 bad-data
Completed, but no date, and reported results 2007-001801-99 An open label study to evaluate the efficacy, safety and tolerability of RWJ333369 as adjunctive therapy in subjects with partial onset seizure bad-data
Listed as ongoing, but also has a completion date and reported results 2007-001985-34 A randomized withdrawal, active- and placebo-controlled, double-blind, multi-center Phase III trial assessing safety and efficacy of oral CG5503 PR* in subjects with moderate to severe chronic maligna... 2009-05-05 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-002111-82 A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Response Study to Evaluate Efficacy and Safety of Prolonged Release (PR) OROS® methylphenidate (54 and 72 mg/day) in A... 2009-04-02 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-002780-27 A randomised, Double blind, placebo controlled trial of long term (2 years) Treatment of Galantamine in mild to moderately severe Alzheimer's Disease (AD) 2012-03-21 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-002929-78 A Randomized, Double-blind, Parallel-group, Multicenter Study to Evaluate the Retention Rate, Efficacy, Safety, and Tolerability of Carisbamate, Topiramate and Levetiracetam as Adjunctive Therapy in S... 2010-05-05 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-003288-36 A Phase 4, Multicenter, Open-Label, Assessor-blinded, Switch Study o fthe Efficacy and Safety of Infliximab (REMICADE) in Patients With Active Rheumatoid Arthritis Who Are Responding Inadequately to E... 2010-06-06 bad-data
Completed, but no date 2007-003464-22 A randomized, Double-Blind, Active-Controlled, Parallel-Group, Noninferiority, Multicenter Study of Ceftobiprole Medocaril Versus Cefepime With or Without Vancomycin in the Treatment of Subjects With ... bad-data
Completed, reported early 2007-003783-22 Daratumumab (HuMax-CD38) safety study in multiple myeloma – Open label, dose-escalation followed by open label, single-arm study 2017-04-03 not-yet-due
Listed as ongoing, but also has a completion date and reported results 2007-004151-11 A Randomized, Open-Label, Multicenter Phase 2 Study of VELCADE With Fludarabine in Comparison to Rituximab With Fludarabine in Follicular Lymphoma Subjects Previously Treated With Rituximab 2011-09-13 bad-data
Ongoing, reported early 2007-004254-93 A Non-Randomized, Within Subject Placebo-Controlled Exploratory Study of the Effects of JNJ-26489112 on the Photic Induced Paroxysmal EEG Response in Subjects with Photosensitive Epilepsy not-yet-due
Reported results 2007-004482-18 A blinded-initiation study of medication satisfaction in subjects with schizophrenia treated with paliperidone ER after suboptimal response to oral risperidone. 2008-07-18 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-004646-33 A Prospective, Randomized, Double-Blind, Double-Dummy, Multicenter Study to Assess the Safety and Efficacy of Doripenem Compared With Imipenem-Cilastatin in the Treatment of Subjects with Ventilator-A... 2011-05-25 bad-data
Ongoing, reported early 2007-005633-10 A Phase 2, Open-Label, Non-Comparative Study of Doripenem in the Treatment of Nosocomial and Ventilator-Associated Pneumonia in Hospitals where Pseudomonas aeruginosa may be a Prevalent Pathogen. not-yet-due
Listed as ongoing, but also has a completion date and reported results 2007-005669-37 A Randomised Open Label, Multicentre Phase 3 Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE and Prednisone (VcR-CAP) or Rituximab, Cyclophosphamide, Doxorubicin, Vincris... 2017-06-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-005837-13 A Phase 3, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate (CB7630) Plus Prednisolone in Patients with Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetax... 2012-10-11 bad-data
Reported results 2007-006175-36 A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effect of JNJ-16269110 on Hepatic Triglyceride Content in Obese Subjects 2008-10-08 due-trials
Completed, but no date, and reported results 2007-006603-20 A Phase 2, 2-Part, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Proof-of-concept, dose-finding Study Evaluating the Efficacy and Safety of CNTO 136 Administered Subcutane... bad-data
Listed as ongoing, but also has a completion date and reported results 2007-006693-28 A Randomised, double blind, Placebo controlled, double dummy, parallel group, multicentre, dose ranging study in subjects with T2DM to evaluate the efficacy, safety, and tolerability of orally adminis... 2009-01-23 bad-data
Reported results 2007-007083-22 A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of JNJ-37822681 Administered Twice Daily in Subjects With Schizoph... 2010-02-01 due-trials
Ongoing 2007-007520-17 A Multicenter, Randomized, Double-Blind, Parallel Group Study to Evaluate the Effect of RWJ-800088 on The Prevention of Chemotherapy-Induced Anemia and The Prevention of Chemotherapy-Induced Thrombocy... not-yet-due
Reported results 2007-007669-20 A Double-Blind, Multiple Dose Titration Study to Investigate the Safety, Tolerability and Pharmacokinetics of Once Daily and Twice Daily Doses of JNJ-37822681 in Male and Female Patients With Stable S... 2009-01-12 due-trials
Completed, but no date, and reported results 2008-000451-97 A Pharmacokinetic and Safety Study of Single and Multiple Doses of Rabeprazole in Pediatric Subjects with GERD 1 to 11 Years old, inclusive bad-data
Ongoing, reported early 2008-000452-27 A Pharmacokinetic, Pharmacodynamic and Safety Study of Single and Multiple Doses of Rabeprazole in Pediatric Subjects with GERD 1 to 11 Months old, Inclusive not-yet-due
Reported results 2008-000529-20 Comparison of Ionsys® and routine care with morphine IV PCA in the management of early post-operative mobilisation, ability to mobilise and in time to Fitness For Discharge (FFD) 2008-11-19 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-000649-77 A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Ustekinumab Therapy in Subjects with Moderately to Severely Active Cr... 2010-12-09 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-000952-28 An Open-label, Randomized Study of Subcutaneous and Intravenous VELCADE® in Subjects With Previously Treated Multiple Myeloma 2011-03-01 bad-data
Ongoing 2008-001173-14 An Open-Label Evaluation of Safety of the IONSYS™ System [Fentanyl Iontophoretic Transdermal System (40 µg)] for Management of Acute Post- Operative Pain in Pediatric Patients not-yet-due
Reported results 2008-001281-86 A Phase 2, Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study Evaluating the Efficacy and Safety of CNTO 888 Administered Intravenously in Sub... 2012-01-18 due-trials
Ongoing 2008-001696-30 A Phase II, open label, single arm trial to evaluate the pharmacokinetics, safety, tolerability, and antiviral activity of rilpivirine (TMC278) in antiretroviral naive HIV1 infected adolescents and ch... not-yet-due
Completed, but no date, and reported results 2008-002074-35 Clinical outcome study in postoperative pain management to demonstrate the efficacy and safety of IONSYS (fentanyl ITS Iontophoretic Transdermal System) in daily clinical practice and to assess its co... bad-data
Ongoing, reported early 2008-002210-22 An Extended Study of CB7630 (Abiraterone Acetate) in Patients with Advanced Prostate Cancer Who Have Failed Androgen Deprivation and Docetaxel-Based Chemotherapy and Completed Clinical Study COU-AA-00... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2008-002247-16 A 24-month, Prospective, Randomized, Active-Controlled, Open-Label, Rater Blinded, Multicenter, International Study of the Prevention of Relapse Comparing Long-Acting Injectable Paliperidone Palmitate... 2014-05-10 bad-data
Reported results 2008-002383-34 A randomised, controlled, open-label trial to compare brachial artery reactivity and cardiovascular risk of a treatment simplification by darunavir/ritonavir (DRV/r) 800/100 mg O.D. versus a triple co... 2011-04-15 due-trials
Completed, but no date, and reported results 2008-002384-13 Efficacy and Tolerability of Flexible Doses of Paliperidone ER in Symptomatic Subjects with Schizophrenia with duration of illness < 10 years bad-data
Reported results 2008-002498-11 PILOT STUDY ON USAGE PATTERNS OF A NOVEL NICOTINE REPLACEMENT THERAPY - A MULTI-CENTER, OPEN, 3-WEEK RANDOMIZED LOW INTERVENTION STUDY OF TWO DIFFERENT DIRECTIONS FOR USE IN SMOKERS MOTIVATED TO QUIT 2008-12-05 due-trials
Completed, but no date 2008-002653-21 Number of Doses and Time to Onset Of Pain Relief (Analgesic Effect) Using the IONSYS™ System [Fentanyl Iontophoretic Transdermal System (40 µg)] bad-data
Listed as ongoing, but also has a completion date and reported results 2008-002708-25 A Randomized, Double-Blind, Placebo-Controlled, Event-Driven Multicenter Study to Evaluate the Efficacy and Safety of Rivaroxaban in Subjects With a Recent Acute Coronary Syndrome 2011-12-20 bad-data
Reported results 2008-002723-85 A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Epoetin Alfa Initiated at 40,000 IU Every Week or 80,000 IU Every Week Versus Placebo in Subjects With IPSS Low- or Interme... 2009-12-18 due-trials
Reported results 2008-003213-27 Randomized Phase III Study on Bortezomib and Low-Dose Dexamethasone with or without Continuous Low-Dose Oral Cyclophosphamide for Primary Refractory or Relapsed Multiple Myeloma 2013-01-08 due-trials
Reported results 2008-003340-11 The “therapeutic window” of the "atypical” antipsychotic paliperidone ER - A Positron Emission Tomography study with [18F]fallypride as the radiotracer 2010-01-13 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-004264-39 A Phase 2, Multicentre, Randomised, Open-Label, Parallel Group Study to Evaluate the Effect of VELCADE® on Myeloma related Bone Disease 2014-04-30 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-004837-54 A Multicenter, Double-Blind, Parallel-Group Study to Evaluate Short-Term Safety and Efficacy and Long-Term Maintenance of Two Dose Levels of Rabeprazole Sodium Delayed-Release Pediatric Bead Formulati... 2011-01-25 bad-data
Reported results 2008-004847-12 A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group, Withdrawal Study to Evaluate the Safety and Efficacy of Delayed-Release Rabeprazole in 1 to 11 Month Old Pediatric Subjects... 2011-11-16 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-005098-37 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Carisbamate as Adjunctive Therapy in Subjects With Partial Onset... 2010-08-31 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-005180-33 A Phase 1/2, Multiple-dose, Dose-escalation Study to Assess the Safety, Efficacy, and Pharmacokinetics of Intravenous CNTO 328, an Anti-interleukin 6 (IL-6) Monoclonal Antibody, in Subjects with Solid... 2011-11-04 bad-data
Ongoing 2008-005237-30 A Multicenter, Prospective, Long-term Registry of Pediatric Patients with Crohn's Disease not-yet-due
Reported results 2008-006064-11 A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects with Active Rheumatoid Arthritis Despite Metho... 2013-02-08 due-trials
Reported results 2008-006845-13 Efficacy and safety following use of a novel nicotine replacement therapy. A multicenter, randomized, double blind, placebo-controlled, parallel group, 52-week study in smokers motivated to quit. 2010-06-16 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-007157-12 A Randomized, Open label, Phase 2 Study of CNTO 328 (Anti IL 6 Monoclonal Antibody) and VELCADE Melphalan Prednisone Compared With VELCADE-Melphalan-Prednisone for the Treatment of Previously Untreate... 2013-03-14 bad-data
Reported results 2008-007478-39 A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 in Subjects With Postherpetic Neuralgia and Post-Trau... 2010-12-23 due-trials
Reported results 2008-007687-41 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Carisbamate as Adjunctive Therapy in Subjects With Partial Onset... 2009-11-23 due-trials
Reported results 2008-007688-17 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Carisbamate as Adjunctive Therapy in Subjects With Partial Onset... 2010-08-31 due-trials
Reported results 2008-007690-21 A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 as Adjunctive Therapy in Subjects With Cancer-Related Pain, Follo... 2015-01-19 due-trials
Reported results 2008-007800-27 A Prospective, Randomized, Active-controlled, Rater-blinded Study of the Prevention of Relapse Comparing Paliperidone Palmitate with Oral Risperidone in Adults with Recently-Diagnosed Schizophrenia Wh... 2010-02-05 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-008004-41 A Phase 3, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate (CB7630) Plus Prednisolone in Asymptomatic or Mildly Symptomatic Patients with Metastatic Castration-Resistant Pros... 2017-05-01 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-008171-34 AN EXPLORATORY TRIAL TO ASSESS NATURALISTIC SAFETY AND EFFICACY OUTCOMES IN PATIENTS TRANSITIONED TO USTEKINUMAB FROM PREVIOUS METHOTREXATE THERAPY (TRANSIT) 2011-08-17 bad-data
Reported results 2008-008444-25 A Phase II, open-label trial with TMC207 as part of a multi-drug resistant tuberculosis (MDR-TB) treatment regimen in subjects with sputum smear-positive pulmonary infection with MDR-TB. 2013-01-24 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-008655-42 A Phase IIb, multi-centre, randomised, double-blind, active-controlled, trial comparing the neuropsychiatric adverse event profile of etravirine 400 mg q.d. versus efavirenz 600 mg q.d. in combination... 2011-01-12 bad-data
Ongoing, reported early 2008-008753-33 A Randomized, Double-Blind, Placebo- and Active-Controlled Study of Carisbamate in the Treatment of Neuropathic Pain in Diabetic Peripheral Neuropathy Followed by a Blinded Extension Phase not-yet-due
Listed as ongoing, but also has a completion date and reported results 2009-009320-36 A Randomized, Double-Blind, 3-Arm Parallel-Group, 2-Year (104-Week), Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ 28431754 100 mg and JNJ-28431754 300 mg Compared With G... 2013-01-21 bad-data
Reported results 2009-009856-19 A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 as Adjunctive Therapy in Subjects With Moderate to Severe Knee or ... 2010-12-23 due-trials
Completed, but no date, and reported results 2009-009857-17 A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Dose-Loading Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 as Adjunctive Therapy in Subjects With Inadequately ... bad-data
Listed as ongoing, but also has a completion date and reported results 2009-010582-23 A Golimumab Phase 3b, Multicenter, Switch Assessment of Subcutaneous and Intravenous Efficacy in Rheumatoid Arthritis Patients Who Have Inadequate Disease Control Despite Treatment with Etanercept (EN... 2013-10-03 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-010714-30 A Phase 2, Multicenter, Randomized, Double blind, Parallel group, Placebo controlled Study Evaluating the Safety and Efficacy of Treatment with Ustekinumab or Golimumab in Subjects with Chronic Sarcoi... 2012-08-17 bad-data
Not reported 2009-011250-17 An Open-label, Multicenter, Phase 2 Study of Single-agent CNTO 888 (an anti- CCL2 Monoclonal Antibody) for the Treatment of Subjects with Recurrent Ovarian Cancer 2010-07-14 due-trials
Reported results 2009-011251-48 An Open-label, Multicenter, Phase 2 Study of Single-agent 2011-07-06 due-trials
Reported results 2009-011309-18 A Prospective, Observational Study of Men With Premature Ejaculation Who Are Treated With PRILIGY™ or Alternate Care 2012-08-31 due-trials
Completed, but no date 2009-011343-39 Patient and physician preferences and satisfaction with oral and long-acting injectable long-term antipsychotic treatment for psychotic disorders bad-data
Reported results 2009-012003-26 Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugs 2011-07-26 due-trials
Reported results 2009-012118-27 A Phase IIa Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of JNJ-38518168 in Subjects with Active Rheumatoid Arthritis Despite Methotrexate Therapy With Synovial Biop... 2010-10-29 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-012140-16 A Randomized, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of JNJ 28431754 on Cardiovascular Outcomes in Adult Subjects With Type 2 Diabetes Mellitus 2017-02-22 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-012264-14 A Phase 3 Multicenter, Randomized, Double-blind, Placebo controlled trial of Ustekinumab, a Fully Human anti-IL 12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects with Active Psori... 2013-05-30 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-012265-60 A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled trial of Ustekinumab, a Fully Human anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects with Active Psori... 2012-11-15 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-012280-34 A Randomized, Open-Label, Multicenter, Phase 2 Study of the Combination of VELCADE, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (VR CAP) or Rituximab, Cyclophosphamide, Doxorubicin, Vincr... 2013-07-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-012380-34 A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of CNTO 328 (Anti-IL-6 Monoclonal Antibody) Plus Best Supportive Care Compared With Best Supportive Care in Subje... 2017-03-01 bad-data
Completed, but no date, and reported results 2009-012444-16 A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Exploratory Study of the Safety and Efficacy of JNJ-39758979 in the Treatment of Adults with Persistent Asthma bad-data
Listed as ongoing, but also has a completion date and reported results 2009-012613-21 An open-label, single-arm, roll-over trial of telaprevir in combination with pegylated interferon alfa-2a (Pegasys) and ribavirin (Copegus) for subjects from the control group of the VX-950-TiDP24-C21... 2012-05-16 bad-data
Reported results 2009-012748-17 A phase 3, multicenter, randomised, double-blind, placebo-controlled, parallel group, efficacy and safety trial of bapineuzumab (AAB-001, ELN115727) in subjects with mild to moderate Alzheimer's disea... 2012-06-05 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-013616-12 A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfu... 2011-08-31 bad-data
Reported results 2009-013689-18 ESTUDIO FASE IV PARA LA EVALUACIÓN DEL EFECTO MODULADOR DE LA GALANTAMINA (REMINYL CLP®) SOBRE EL RITMO CIRCADIANO DE PACIENTES CON ENFERMEDAD DE ALZHEIMER MODERADA 2011-06-28 due-trials
Reported results 2009-013929-42 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of JNJ-39588146 in Subjects with Heart Failure 2011-11-21 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-014368-20 A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Ustekinumab in the Treatment of Adolescent Subjects With Moderate to Severe Plaque-type ... 2014-01-04 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-014387-20 An Open-Label Study to Evaluate the Single-Dose Pharmacokinetics, Safety, and Tolerability of Doripenem in Infants (Term and Preterm), Less Than 12 Weeks Chronological Age 2012-04-30 bad-data
Ongoing, reported early 2009-014811-11 A randomized, multicenter, double-blind, active-controlled, flexible-dose, parallel-group study of the efficacy and safety of prolonged release paliperidone for the treatment of symptoms of schizophre... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2009-015019-42 A Multicenter, Double Blind, Randomized-Withdrawal Trial of Subcutaneous Golimumab, a Human Anti-TNFα Antibody, in Pediatric Subjects with Active Polyarticular Course Juvenile Idiopathic Arthritis (JI... 2014-06-27 bad-data
Ongoing, reported early 2009-015629-35 Open-label, single arm, interventional study to explore the efficacy and safety of paliperidone ER in the management of patients with acute agitation and/or aggression not-yet-due
Listed as ongoing, but also has a completion date and reported results 2009-015864-32 A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infec... 2013-08-05 bad-data
Reported results 2009-015870-36 Nicotine pharmacodynamics with a new oral nicotine replacement product and NiQuitin Lozenge. A study in healthy smokers. 2010-05-19 due-trials
Reported results 2009-015883-32 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 26-Week, Multicenter Study with a 26 Week Extension to Evaluate the Efficacy, Safety, and Tolerability of JNJ 28431754 as Monotherapy in... 2012-03-20 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-015885-75 A Pharmacokinetic, Pharmacodynamic and Short-term Safety Study of Single and Multiple Day Doses of Rabeprazole Sodium in Neonates and Pre-term Infants with a Corrected Age of Less than 44 Weeks with a... 2012-01-11 bad-data
Completed, but no date 2009-015931-33 An open label, prospective, multicenter, single-arm clinical trial to investigate the safety and the analgesic effectiveness of a low dose (4 mg) OROS hydromorphone hydrochloride as starting dose in... bad-data
Listed as ongoing, but also has a completion date and reported results 2009-015953-18 A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infectio... 2013-08-05 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-016069-27 A Prospective, Randomized, Double-Blind, Multicenter Study to 2013-08-05 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-016366-88 A Randomized, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Multicenter Study, to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 D... 2012-04-17 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-016525-34 A Randomized, Double-Blind, Placebo and Active-Controlled, 4-Arm, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-28431754 (Canagliflozin) Compared with Si... 2012-05-29 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-017013-29 Acceso continuado a darunavir/ritonavir (DRV/rtv) de niños y adolescentes de 3 o más años de edad infectados por el VIH-1 2017-11-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-017136-40 A Randomized, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, 26-Week, Multicenter Study With a 26-Week Extension, to Evaluate the Efficacy, Safety and Tolerability of Canagliflozin in the T... 2012-07-23 bad-data
Listed as ongoing, but also has a completion date 2009-017237-22 A Phase 3, Randomized, Double-blind Study of Siltuximab (Anti-IL-6 Monoclonal Antibody) or Placebo in Combination With VELCADE and Dexamethasone for the Treatment of Subjects With Relapsed or Refracto... 2011-09-08 bad-data
Reported results 2009-017271-17 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Paliperidone Palmitate Evaluating Time to Relapse in Subjects With Schizoaffective Disorder 2013-10-22 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-018022-30 A 6-month, open label, prospective, multicenter, international, exploratory study of a transition to flexibly dosed paliperidone palmitate in patients with schizophrenia previously unsuccessfully tre... 2013-11-29 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-018070-64 A Randomized, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, 26 Week Multicenter Study with a 26-Week Extension to Evaluate the Efficacy, Safety, and Tolerability of JNJ 28431754 (Canagliflo... 2012-06-29 bad-data
Reported results 2009-018109-29 A PHASE 3 MULTI-CENTER PARALLEL DESIGN CLINICAL TRIAL TO COMPARE THE EFFICACY AND SAFETY OF 5% MINOXIDIL FOAM VS. 2% MINOXIDIL SOLUTION IN FEMALES FOR THE TREATMENT OF FEMALE PATTERN HAIR LOSS (ANDROG... 2012-02-15 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-018411-15 A Randomized, Double-Blind, Placebo-controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin Compared With Placebo in the Treatment of Older Su... 2013-05-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-018431-18 Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Comparing REMICADE (infliximab) and Placebo in the Prevention of Recurrence in Crohn’s Disease Patients Undergoing Surgic... 2014-12-12 bad-data
Reported results 2010-019843-20 A Prospective 3-Year Follow-up Study in Subjects Previously Treated in a Phase IIb or Phase III Study With a TMC435-Containing Regimen for the Treatment of Hepatitis C Virus (HCV) infection 2016-01-05 due-trials
Reported results 2010-019881-96 A PHASE 3 MULTI-CENTER PARALLEL DESIGN CLINICAL TRIAL TO COMPARE THE EFFICACY AND SAFETY OF 5% MINOXIDIL FOAM VS. VEHICLE IN FEMALES FOR THE TREATMENT OF FEMALE PATTERN HAIR LOSS (ANDROGENETIC ALOPECI... 2011-08-30 due-trials
Reported results 2010-020053-14 A Randomized, Double-Blind, Active-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin Versus Sitagliptin in the Treatment of Subjects With Type 2 Diabete... 2012-03-09 due-trials
Other 2010-020380-20 Open-Label Evaluation of the Pharmacokinetic Profile and Safety of Tapentadol Oral Solution for the Treatment of Postsurgical Pain in Children and Adolescents Aged From 6 to Less Than 18 Years not-yet-due
Listed as ongoing, but also has a completion date and reported results 2010-020444-36 A Phase III, randomized, double-blind, placebo-controlled study to investigate the efficacy, safety and tolerability of TMC435 vs. placebo as part of a treatment regimen including peginterferon alfa-2... 2013-01-29 bad-data
Reported results 2010-020968-38 A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment with CNTO 136 Administered Intravenously in Subjects with Active Lupus ... 2013-09-24 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-021113-23 A Phase III, randomized, double-blind, placebo-controlled study to investigate the efficacy, safety and tolerability of TMC435 vs. placebo as part of a treatment regimen including peginterferon alfa-2... 2013-02-04 bad-data
Reported results 2010-021125-12 Early access of TMC207 in combination with other anti-tuberculosis (TB) drugs in subjects with extensively drug resistant (XDR) or pre-XDR pulmonary TB 2016-12-01 due-trials
Reported results 2010-021174-11 A Phase III, randomized, double-blind, placebo-controlled study to investigate the efficacy, safety and tolerability of TMC435 versus placebo as part of a treatment regimen including peginterferon α-2... 2013-02-05 due-trials
Ongoing 2010-021209-18 An open-label trial with TMC278 25 mg q.d. in combination with a background regimen containing 2 nucleoside/nucleotide reverse transcriptase inhibitors in HIV-1 infected subjects, who participated in ... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2010-021337-31 A Phase III open-label study to evaluate the safety, tolerability and efficacy of TMC435 plus PegIFN?-2a (Pegasys)® and ribavirin (Copegus)® triple therapy in chronic hepatitis C genotype-1 infected s... 2013-08-28 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-021425-13 An Open Label Study of Abiraterone Acetate in Subjects with Metastatic Castration-Resistant Prostate Cancer Who Have Progressed After Taxane-Based Chemotherapy 2015-10-19 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-021628-84 A randomized, open-label, Phase 3 study of telaprevir administered twice daily or every 8 hours in combination with pegylated interferon alfa-2a and ribavirin in treatment-naïve subjects with genotype... 2012-11-28 bad-data
Reported results 2010-022242-24 A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of CNTO 136 (sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Subjects with Active R... 2016-12-06 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-022243-38 A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of CNTO 136 (sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Subjects with Active R... 2016-01-12 bad-data
Reported results 2010-022437-28 A Randomized, Double-Blind, Placebo- and Active-Controlled Crossover Study to Evaluate the Efficacy of JNJ 40929837 for the Treatment of Asthma Using a Bronchial Allergen Challenge Model 2011-06-06 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-022758-18 A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Subjects with Moderately to Severely ... 2013-07-16 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-022759-42 A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Subjects with Moderately to Severely ... 2014-10-28 bad-data
Ongoing 2010-022760-12 A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Subjects with Moderately to Severel... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2010-022837-27 An Open-label, Multicenter Study to Evaluate the Safety of Long-term Treatment with Siltuximab in Subjects with Multicentric Castleman's Disease 2017-03-01 bad-data
Reported results 2010-022884-36 A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Epoetin Alfa Versus Placebo in Anemic Patients with IPSS Low- or intermediate 1 Risk Myelodysplastic Syndromes 2016-01-07 due-trials
Reported results 2010-023268-42 NICOTINE PHARMACODYNAMICS WITH A NEW ORAL NICOTINE REPLACEMENT PRODUCT AND NICOTINE GUM 4 MG. A STUDY IN HEALTHY SMOKERS. 2011-08-25 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-023369-23 FIRST-IN-PATIENT STUDY TO ASSESS THE SAFETY AND TOLERABILITY AND TO EXPLORE THE POTENTIAL THERAPEUTIC EFFICACY OF A NOVEL GLUTAMATE MODULATOR AS MONOTHERAPY AND AS ADD-ON THERAPY IN PATIENTS WITH SCHI... 2012-12-05 bad-data
Ongoing, reported early 2010-023532-16 An open-label study to evaluate the safety, tolerability and pharmacokinetics of etravirine (ETR) in combination with other antiretrovirals (ARVs) in antiretroviral treatment-experienced HIV-1 infecte... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2010-023669-23 Multicenter, Open-Label, Early Access Program of Telaprevir in Combination With Peginterferon Alfa and Ribavirin in Genotype 1 Chronic Hepatitis C Subjects With Severe Fibrosis and Compensated Cirrhos... 2014-05-30 bad-data
Reported results 2010-024256-28 A Randomized, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Di... 2012-04-20 due-trials
Reported results 2011-000261-12 A Phase 2, Randomized, Double-blind, Placebo-controlled, Multicenter Study Comparing Siltuximab Plus Best Supportive Care to Placebo Plus Best Supportive Care in Anemic Subjects with International Pro... 2012-09-13 due-trials
Reported results 2011-000400-17 A Randomized, Double-Blind, 5-Arm, Parallel-Group, 26-Week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in Combination With Metformin as Initial Combination T... 2014-12-02 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-000416-25 A Phase III, open-label trial of TMC435 in combination with peginterferon alpha-2a and ribavirin for HCV genotype-1 infected subjects who participated in the placebo group of a Phase II/III TMC435 stu... 2015-03-31 bad-data
Listed as ongoing, but also has a completion date and reported results 2011-000554-31 A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Evaluating the Efficacy and Safety of Ustekinumab in Subjects with Primary Biliary Cirrhosis Who had an Inad... 2013-06-28 bad-data
Ongoing 2011-000621-80 Randomized, Open-Label Study of Abiraterone Acetate (JNJ 212082) plus Prednisone/ Prednisolone with or without Exemestane in Postmenopausal Women with ER+ Metastatic Breast Cancer Progressing after Le... not-yet-due
Not reported 2011-000653-23 A Phase III placebo-controlled, double-blind, randomized trial to evaluate the efficacy and safety of TMC207 in subjects with sputum smear-positive pulmonary infection with multi-drug resistant Mycoba... 2013-12-19 due-trials
Reported results 2011-001066-17 A Phase 2 Multicenter, Randomized, Placebo- and Active-Comparator-Controlled, Dose-Ranging Trial to Evaluate CNTO 1959 for the Treatment of Subjects with Moderate to Severe Plaque-type Psoriasis (X-PL... 2013-08-05 due-trials
Reported results 2011-001076-18 A Phase 2, Randomized, Open-label, Multicenter Study of the Histone Deacetylase Inhibitor (HDACi) JNJ-26481585 at Two Dose Levels in Subjects With Previously Treated Stage Ib-IVa Cutaneous T-cell Lymp... 2016-07-22 due-trials
Completed, reported early 2011-001114-33 An Open-Label Study to Evaluate the Penetration of Doripenem in Cerebrospinal Fluid After Doripenem Administration in Pediatric Subjects Less Than 1 Year 2013-07-01 not-yet-due
Reported results 2011-001122-18 A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy and Safety of Ustekinumab (STELARA®) and CNTO 1959 Administered Subcutaneously in Su... 2014-05-05 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-001180-53 A Phase III, randomized, double-blind trial to evaluate the efficacy, safety and tolerability of TMC435 vs. telaprevir, both in combination with PegIFN?-2a and ribavirin, in chronic hepatitis C genoty... 2014-04-07 bad-data
Reported results 2011-001303-13 HIV postexposure prophylaxis with Darunavir/r (PEPDar) 2013-09-28 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-001635-23 PROTEAse inhibitor (DRV/rtv) in mono- or triple therapy in suppressed HIV-1 infected subjects 2015-03-18 bad-data
Ongoing 2011-001735-22 A Phase 2, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Siltuximab (Anti IL 6 Monoclonal Antibody) in Subjects with High-risk Smoldering Multiple Myeloma not-yet-due
Reported results 2011-002133-20 A Phase 3 Extension, Multicenter, Double-Blind, Long Term Safety and Tolerability Treatment Trial of Bapineuzumab (AAB-001, ELN115727) in Subjects with Alzheimer's Disease Who Participated in Study EL... 2012-09-30 due-trials
Completed, reported early 2011-002796-41 A PROOF OF CONCEPT WITH A NEW NICOTINE INHALER IN COMPARISON WITH NICOTINE INHALER 10 MG 2011-12-14 not-yet-due
Reported results 2011-002840-29 A Phase 2b Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group, Dose Range Finding Study of JNJ–38518168 in Subjects with Active Rheumatoid Arthritis Despite Concomitant Methotre... 2014-07-03 due-trials
Completed, but no date 2011-002849-36 A Phase 2b Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group, Dose Range Finding Study of JNJ-39758979 in Subjects with Active Rheumatoid Arthritis Despite Concomitant Methotre... bad-data
Listed as ongoing, but also has a completion date and reported results 2011-003593-85 Multicenter, Open-Label Study of Telaprevir in Combination With Peginterferon Alfa and Ribavirin in Human Immunodeficiency Virus/Genotype 1 Chronic Hepatitis C Coinfected Subjects With Severe Fibrosis... 2014-08-26 bad-data
Reported results 2011-004097-29 An Open-Label, Single-Arm Phase III Study to Evaluate the Efficacy, Safety and Tolerability of TMC435 in Combination With PegIFN alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment-Naïve or Treatme... 2014-02-20 due-trials
Reported results 2011-004529-28 A Phase 2a, Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Study of JNJ-40346527 in Subjects with Active Rheumatoid Arthritis Despite Disease-modifying Antirheumatic Drug Th... 2013-03-25 due-trials
Reported results 2011-004676-11 A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects with Schizophrenia 2014-04-04 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-004724-35 Open-Label, Phase 3b Study To Determine Efficacy and Safety of Telaprevir, Pegylated-Interferon-alfa-2a and Ribavirin in Hepatitis C Genotype 1 Infected, Stable Liver Transplant Subjects 2014-07-24 bad-data
Reported results 2011-004795-11 A Randomized, Controlled Phase 3 Study to Evaluate Optimized Retreatment and Prolonged Therapy with Bortezomib (Velcade) in Patients with Multiple Myeloma in First or Second Relapse 2016-02-18 due-trials
Reported results 2011-004889-15 A Randomized, Multicenter, Double-Blind, Non-inferiority Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Subjects with Schizophrenia 2015-04-07 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-004928-35 Open-Label, Phase 3b Study to Determine Efficacy and Safety of Telaprevir, Pegylated-Interferon-alfa-2a and Ribavirin in Hepatitis C Virus Treatment-Naïve and Treatment-Experienced Subjects with Genot... 2014-06-03 bad-data
No trial status on register 2011-005159-15 An Open-Label, Parallel-Group Study to Evaluate the Single-Dose Pharmacokinetics and Safety of Doripenem in bad-data
Listed as ongoing, but also has a completion date 2011-005243-28 A Phase 3bMulticenter, Open-label Abiraterone Acetate Long-term Access Study 2012-09-05 bad-data
Listed as ongoing, but also has a completion date and reported results 2011-005479-17 A Single Blind, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of EVICEL® as an Adjunct to Gastrointestinal Anastomosis Techniques 2014-01-06 bad-data
Completed, report not yet due 2011-005692-16 An Open-label, International, Multicenter, Dose Escalating 2013-03-01 not-yet-due
Ongoing 2011-005709-62 An Open label, International, Multicenter, Dose Escalating Phase 1/2 Trial Investigating the Safety of Daratumumab in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed or Relap... not-yet-due
Completed, reported early 2011-005795-42 An Open-label, Multicenter Phase 1/2 Study of JNJ-40346527, an FMS Inhibitor, in Subjects with Relapsed or Refractory Hodgkin Lymphoma 2013-08-13 not-yet-due
Reported results 2011-005808-14 A Phase I, open-label, randomized, 3-panel, 3-way crossover trial in healthy adult subjects to assess the relative bioavailability of TMC435 following administration of 2 liquid formulations or 2 diff... 2012-05-29 due-trials
Reported results 2011-005992-17 A Double-Blind, Double-Randomization, Placebo-Controlled Study of the Efficacy of Intravenous Esketamine in Adult Subjects with Treatment-Resistant Depression 2013-06-03 due-trials
Reported results 2011-006121-26 A Multicenter, Double-Blind, Placebo-Controlled Study of JNJ-40411813 as Adjunctive Treatment to an Antidepressant in Adults with Major Depressive Disorder with Anxiety Symptoms 2013-11-25 due-trials
Ongoing 2012-000600-15 Randomized, Double-blind, Placebo-controlled Phase 3 Study of Ibrutinib, a Bruton's Tyrosine Kinase (BTK) Inhibitor, in Combination with Bendamustine and Rituximab (BR) in Subjects With Relapsed or Re... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2012-000601-74 A Randomized, Controlled, Open-Label, Multicenter Phase 3 Study of the Bruton’s Tyrosine Kinase (Btk) Inhibitor, Ibrutinib, Versus Temsirolimus in Subjects with Relapsed or Refractory Mantle Cell Lymp... 2016-12-15 bad-data
Reported results 2012-000711-88 A Phase 2, Multicenter, Single-Arm, Study to Evaluate the Efficacy and Safety of Single-Agent Bruton’s Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Subjects with Mantle Cell Lymphoma Who Progress af... 2015-05-31 due-trials
Listed as ongoing, but also has a completion date 2012-001176-10 A Multicenter, Parallel-group Study of Long-term Safety and Efficacy of CNTO 136 (sirukumab) for Rheumatoid Arthritis in Subjects Completing Treatment in Studies CNTO136ARA3002 (SIRROUND-D) and CNTO13... 2018-05-01 bad-data
Listed as ongoing, but also has a completion date and reported results 2012-001484-79 A Randomized, Open-label, Active-controlled Multi-center Study to Evaluate the Safety of Rivaroxaban and Vitamin K Antagonists in Subjects Undergoing Catheter Ablation for Atrial Fibrillation 2014-10-29 bad-data
Listed as ongoing, but also has a completion date and reported results 2012-001491-11 An OPen-label, Randomized, Controlled, Multicenter Study ExplorIng TwO TreatmeNt StratEgiEs of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects With Atrial Fibr... 2016-07-29 bad-data
Other 2012-001552-19 A Randomized, Active-Controlled, Open-Label, Flexible-Dose Study to Assess the Safety and Tolerability of Topiramate as Monotherapy Compared with Levetiracetam as Monotherapy in Pediatric Subjects wit... not-yet-due
Reported results 2012-002555-42 A Phase IIa, open-label trial to evaluate the safety, tolerability and efficacy of a 12 weeks combination therapy of TMC647055 and TMC435 with and without GSK2336805 with a pharmacokinetic enhancer wi... 2016-01-25 due-trials
Ongoing 2012-002940-26 A Randomized, Double-blind, Comparative Study of Abiraterone Acetate Plus Low-dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Subjects With High-Risk, Metas... not-yet-due
Reported results 2012-002954-21 An exploratory, blinded, randomized, placebo-controlled study in subjects with depressive disorder to investigate the effect of minocycline on relapse after successful intravenous ketamine/minocycline... 2014-07-10 due-trials
Reported results 2012-003607-36 A Randomized, Placebo-controlled, Double-blind, Multi-center, Phase 2 Study to Assess the Efficacy and Safety of CNTO 6785 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease 2015-09-28 due-trials
Reported results 2012-003629-40 A Randomized, Placebo-controlled Double-blind, Multicenter, Phase 2 Dose Ranging Study To Assess The Efficacy And Safety of CNTO6785 In Subjects With Active Rheumatoid Arthritis Despite Methotrexate T... 2015-05-26 due-trials
Ongoing 2012-004056-11 A Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor, PCI-32765 (Ibrutinib), in Combination with Bendamustine and Rituximab (BR) in Subjects Wit... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2012-004097-26 An Open-label, Multicenter, Single-arm, Phase 2 Study of PCI-32765 (ibrutinib) in Subjects with Refractory Follicular Lymphoma 2016-05-18 bad-data
Ongoing 2012-004225-24 A Phase 3b, Multicenter, Open-label, PCI-32765 (Ibrutinib) Long-term Extension Study not-yet-due
Ongoing 2012-004331-23 A Randomized Phase 2 Study Evaluating Abiraterone Acetate With Different Steroid Regimens for Preventing Symptoms Associated With Mineralocorticoid Excess in Asymptomatic, Chemotherapy-Naïve and Metas... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2012-004359-35 An evaluation of the efficacy and safety of tapentadol oral solution in the treatment of post-operative acute pain requiring opioid treatment in pediatric subjects aged from birth to less than 18 year... 2016-12-05 bad-data
Ongoing 2012-004366-18 A Phase 1b Open-Label Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human anti-TNFα Antibody, in Pediatric Subjects with Moderately to Severely Active Ulc... not-yet-due
Ongoing 2012-004808-34 A Randomized, Open-Label Study Comparing the Combination of YONDELIS and DOXIL/CAELYX With DOXIL/CAELYX Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fa... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2012-004905-29 A Phase 3, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of TMC435 plus Pegylated Interferon alfa-2a and Ribavirin Administered for 12 Weeks in Treatment-Naïve Subjects with Chronic... 2015-08-30 bad-data
Listed as ongoing, but also has a completion date and reported results 2012-004920-39 A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group Study of JNJ-38518168 in Symptomatic Adult Subjects with Uncontrolled, Persistent Asthma 2015-07-22 bad-data
Reported results 2012-005184-27 A Phase 2 Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of Inhaled JNJ-49095397 (RV568) in Subjects with Moderate to Severe Chronic Obstructive Pulmonary Disease. 2014-10-29 due-trials
Reported results 2012-005492-13 A Phase I, open-label, randomized, 3-way crossover study in 3 Panels of healthy, adult subjects to assess the relative bioavailability of TMC207 following single-dose administration of two pediatric f... 2013-08-26 due-trials
Listed as ongoing, but also has a completion date 2013-000046-19 A Randomized, Double-blind, Event-driven, Multicenter Study Comparing the Efficacy and Safety of Oral Rivaroxaban with Placebo for Reducing the Risk of Death, Myocardial Infarction or Stroke in Subjec... 2018-04-19 bad-data
Listed as ongoing, but also has a completion date and reported results 2013-000263-88 A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-response Study Evaluating the Efficacy and Safety of JNJ-54781532 in Subjects with Moderately to Severely Ac... 2015-12-05 bad-data
Listed as ongoing, but also has a completion date and reported results 2013-000390-70 Phase 1-2 Safety and Efficacy Study of DACOGEN in Sequential Administration With Cytarabine in Children With Relapsed or Refractory Acute Myeloid Leukemia. 2017-08-28 bad-data
Completed, but no date, and reported results 2013-000752-18 An Open-label, Multicenter, Phase 2 Trial Investigating the Efficacy and Safety of Daratumumab in Subjects With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Protea... bad-data
Ongoing 2013-000959-40 A Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor, PCI-32765 (Ibrutinib), in Combination with Rituximab, Cyclophosphamide, Doxorubicin, Vincr... not-yet-due
Reported results 2013-001417-32 A Multicenter, Randomized, Double-blind, Parallel Group Study of CNTO 136 (sirukumab) Administered Subcutaneously as Monotherapy Compared With Adalimumab Monotherapy, in Subjects with Active Rheumatoi... 2016-08-17 due-trials
Reported results 2013-001442-34 A SINGLE-DOSE, RANDOMIZED, TWO-PERIOD, CROSSOVER STUDY TO ASSESS BIOEQUIVALENCE BETWEEN TWO IBUPROFEN 200 MG TABLET FORMULATIONS, IN HEALTHY ADULTS. 2013-09-24 due-trials
Reported results 2013-001830-16 Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Adjunctive Therapy in Subjects with Signs and Symptoms of O... 2016-09-19 due-trials
Listed as ongoing, but also has a completion date and reported results 2013-002042-36 A Phase 2a Open-label Study to Evaluate Prediction of Response to Golimumab Using a Transcriptomic Profile in Subjects with Moderately to Severely Active Ulcerative Colitis 2016-01-29 bad-data
Reported results 2013-002535-24 A Phase III Randomized, Controlled, Superiority Study Evaluating EVARREST™ Fibrin Sealant Patch Versus Standard of Care Treatment in Controlling Parenchymal Bleeding During Hepatic Surgery 2014-09-22 due-trials
Completed, but no date, and reported results 2013-002726-23 Phase 2, Open-Label Study to Investigate the Pharmacokinetics, Efficacy, Safety, and Tolerability of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052) and Ribavirin (RBV) in Patients wi... bad-data
Listed as ongoing, but also has a completion date and reported results 2013-003050-25 A Randomized, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Canagliflozin on Renal Endpoints in Adult Subjects With Type 2 Diabetes Mellitus 2017-02-27 bad-data
Listed as ongoing, but also has a completion date 2013-003093-27 A Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Bruton's Tyrosine Kinase Inhibitor, PCI-32765 (Ibrutinib), in Combination with Either Bendamustine and Rituximab (BR) or Rituximab,... 2018-01-29 bad-data
Reported results 2013-003548-22 Four Week Clinical Efficacy of An Ethyl Lauroyl Arginate HCL (LAE) Mouth Rinse: Effect on Gingivitis 2014-07-31 due-trials
Ongoing, reported early 2013-004005-11 A Double-Blind, Doubly-Randomized, Placebo-Controlled Study of Intranasal Esketamine in an Adaptive Treatment Protocol to Assess Safety and Efficacy in Treatment-Resistant Depression (SYNAPSE) not-yet-due
Ongoing 2013-004494-28 A Randomized, Double-blind, Event-driven, Placebo-controlled, Multicenter Study of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Subjects With Type 2 Diabetes Mellitus and Diabe... not-yet-due
Reported results 2013-004819-40 A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects with ... 2015-09-11 due-trials
Listed as ongoing, but also has a completion date 2013-005104-33 A Randomized, Double-blind, Placebo-controlled, 2-Part Study of Orally Administered ALS-008176 to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Dosing an... 2018-02-15 bad-data
No trial status on register 2013-005455-32 Open-Label, Multicenter, Multiple Oral Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Canagliflozin in Older Children and Adolescents ≥10 to <18 years of age with Type 2 D... bad-data
Ongoing 2013-005525-23 Phase 3 Study Comparing Daratumumab, Lenalidomide, and Dexamethasone (DRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed or Refractory Multiple Myeloma not-yet-due
Reported results 2014-000241-74 A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNFα Monoclonal Antibody, Administered Intravenously, in Subjects with Active Ankylosing Spondylitis 2016-10-11 due-trials
Reported results 2014-000242-30 A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, an Anti-TNF alpha Monoclonal Antibody, Administered Intravenously, in Subjects with Active Psoriatic Arthritis 2017-03-22 due-trials
Ongoing 2014-000255-85 Phase 3 Study Comparing Daratumumab, Bortezomib and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in Subjects With Relapsed or Refractory Multiple Myeloma not-yet-due
Listed as ongoing, but also has a completion date 2014-000305-13 Medically Ill Patient Assessment of Rivaroxaban Versus Placebo IN Reducing Post-Discharge Venous Thrombo-Embolism Risk 2018-04-02 bad-data
Ongoing 2014-000719-15 A Phase 3, Multicenter, Randomized, Double-blind, Placebo and Active Comparator-controlled Study Evaluating the Efficacy and Safety of Guselkumab for the Treatment of Subjects with Moderate to Severe ... not-yet-due
Ongoing 2014-000720-18 A Phase 3, Multicenter, Randomized, Double-blind, Placebo and Active Comparator controlled Study Evaluating the Efficacy and Safety of Guselkumab for the Treatment of Subjects with Moderate to Severe ... not-yet-due
Reported results 2014-000721-20 A Phase 3, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Guselkumab for the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis and an Inadequate R... 2016-05-24 due-trials
Ongoing 2014-001718-25 A Phase 3 Randomized, Placebo-controlled Double-blind Study of JNJ-56021927 in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Subjects with Chemothera... not-yet-due
Reported results 2014-002159-24 A Phase 2a Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multi-center Study Investigating the Safety and Tolerability of JNJ-54861911 in Subjects in the Early (Predementia) Alzheimer’s... 2016-06-07 due-trials
Ongoing 2014-002272-88 A Phase 3, Randomized, Controlled, Open-label Study of VELCADE (Bortezomib) Melphalan- not-yet-due
Ongoing 2014-002273-11 A Phase 3 Study Comparing Daratumumab, Lenalidomide, and Dexamethasone (DRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects with Previously Untreated Multiple Myeloma who are Ineligible for High D... not-yet-due
Ongoing 2014-002408-26 A Phase 2, Two-arm Multicenter, Open-Label Study to Determine the Efficacy and the Safety of Two Different Dose Regimens of a pan-FGFR Tyrosine Kinase Inhibitor JNJ-42756493 in Subjects with Metastati... not-yet-due
No trial status on register 2014-002471-28 An open-label, roll-over study with rilpivirine in combination with a background regimen containing 2 nucleoside/nucleotide reverse transcriptase inhibitors (N[t]RTIs) in human immunodeficiency virus ... bad-data
Listed as ongoing, but also has a completion date and reported results 2014-002598-13 Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects with Signs and Symptoms of Osteoart... 2016-10-10 bad-data
Listed as ongoing, but also has a completion date 2014-003052-31 A Phase 3, randomized, active-controlled, open-label study to evaluate switching to a darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) once-daily single tablet regimen versus conti... 2018-04-26 bad-data
Listed as ongoing, but also has a completion date and reported results 2014-003224-40 Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Fulranumab as Adjunctive Therapy in Subjects with Signs and Symptoms of O... 2016-09-19 bad-data
No trial status on register 2014-003372-23 A Phase 2, Open-label, Multicenter, Single-arm Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Antimycobacterial Activity of TMC207 in Combination With a Background Regimen (BR) of Mu... bad-data
Listed as ongoing, but also has a completion date and reported results 2014-003413-28 A Phase 2, Open-label Study to Investigate the Efficacy and Safety of the Combination of Simeprevir and Daclatasvir in Chronic Hepatitis C Genotype 1b-Infected Subjects 2016-04-11 bad-data
Reported results 2014-003446-27 A Phase 3, Multicenter, Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of a 12-Week Regimen of Simeprevir in Combination with Sofosbuvir in Treatment-Naïve or -Experienced Subject... 2015-12-23 due-trials
Listed as ongoing, but also has a completion date 2014-003679-48 A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF alpha Naive Subjects With Active Radiographic ... 2017-05-17 bad-data
Listed as ongoing, but also has a completion date and reported results 2014-003697-17 A Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Guselkumab in the Treatment of Subjects With Active Psoriatic Arthritis 2017-01-17 bad-data
Ongoing, reported early 2014-003879-37 Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects with Signs and Symptoms of Osteoart... not-yet-due
Reported results 2014-004068-39 A Phase 2b, Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Multicenter Study of 2 Dose Levels of VX 787 Administered as Monotherapy and One Dose Level of VX-787 Administered in Combinat... 2016-07-07 due-trials
Completed, but no date 2014-004250-34 A Phase 2, Open-label, Single-arm Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of 12 Weeks Treatment With Simeprevir and Daclatasvir in Subjects With Chronic Hepatitis ... bad-data
Reported results 2014-004266-26 A Randomized, Double-blind, Double-dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Tic... 2016-10-14 due-trials
Listed as ongoing, but also has a completion date 2014-004274-41 A Randomized, Two-Period, Double-Blind Placebo-Controlled and Open-Label, Multicenter Extension Study to Determine the Long-Term Safety and Tolerability of JNJ-54861911 in Subjects in the Early Alzhei... 2018-06-28 bad-data
Completed, report not yet due 2014-004584-20 A Randomized, Double-blind, Multicenter, Active-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Subject... 2018-02-20 not-yet-due
Completed, report not yet due 2014-004585-22 A Randomized, Double-blind, Multicenter, Active-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Subj... 2017-11-06 not-yet-due
Completed, report not yet due 2014-004586-24 A Randomized, Double-blind, Multicenter, Active-Controlled Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Treatment-resistant Depression 2018-02-16 not-yet-due
Listed as ongoing, but also has a completion date 2014-004587-38 An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression 2017-10-30 bad-data
Listed as ongoing, but also has a completion date 2014-004588-19 A Randomized, Double-blind, Multicenter, Active-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Subjects with Treatm... 2017-08-10 bad-data
Ongoing 2014-005000-19 A Multicenter, Randomized, Double-blind, Placebo-controlled, Proof-of-Concept Study of Ustekinumab in Subjects With Active Systemic Lupus Erythematosus not-yet-due
Ongoing, reported early 2014-005041-41 A Phase 2a, randomized, double-blinded, placebo-controlled study to evaluate the antiviral activity, safety, and pharmacokinetics of repeated doses of orally administered JNJ-53718678 against Respirat... not-yet-due
Ongoing 2014-005139-14 A Randomized Phase 2 Trial to Evaluate Three Daratumumab Dose Schedules in Smoldering Multiple Myeloma not-yet-due
Ongoing 2014-005206-37 A Double-Blind, Placebo-Controlled, Multicenter Study of Sirukumab as Adjunctive Treatment to a MonoAminergic antidepressant in Adults with Major Depressive Disorder not-yet-due
Completed, but no date, and reported results 2014-005299-26 An Open Label, Phase 2 Study to Evaluate Efficacy and Safety of Daratumumab in Relapsed or bad-data
Ongoing, reported early 2014-005448-17 A Phase 1, open-label, randomized, 2-panel, 3-way crossover study in healthy adult subjects to assess the relative bioavailability of simeprevir following single dose administration of age-appropriate... not-yet-due
Ongoing 2014-005606-38 A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects with Mode... not-yet-due
Reported results 2015-000277-12 A Phase 2 Multicenter, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Toreforant (JNJ-38518168) for the Treatment of Subjects with Moderate to Severe Plaquetype Psoriasis 2016-03-11 due-trials
Listed as ongoing, but also has a completion date 2015-000288-16 A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF (alpha) Refractory Subjects With Active Radiog... 2017-05-17 bad-data
Ongoing 2015-000289-67 A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Ustekinumab in the Treatment of Subjects With Active Nonradiographic Axial Spondyloarth... not-yet-due
Completed, but no date, and reported results 2015-000459-25 A Phase 2, 2-panel, Open-label, Randomized Study to Investigate the Pharmacokinetic Interactions Between Simeprevir and Ledipasvir in a Treatment Regimen Consisting of Simeprevir, Sofosbuvir, and Ledi... bad-data
Other 2015-000596-27 A Randomized, Observer-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety, Tolerability and Immunogenicity of Three Prime-Boost Regimens of the Candidate Prophylactic Vaccines for Ebola A... not-yet-due
Ongoing 2015-000735-32 A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Apalutamide Plus Androgen Deprivation Therapy (ADT) Versus ADT in Subjects with Metastatic Hormone-sensitive Prostate Cancer (mHSPC) not-yet-due
Ongoing 2015-000754-38 A Phase 3, randomized, active-controlled, double-blind study to evaluate efficacy and safety of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) once daily fixed dose combination r... not-yet-due
Other 2015-000946-41 A Randomized, Single-Blind, Multicenter Phase 2 Study to Evaluate the Activity of 2 Dose Levels of Imetelstat in Subjects with Intermediate-2 or High-Risk Myelofibrosis (MF) Relapsed/Refractory to Jan... not-yet-due
Other 2015-000948-42 A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy and Safety of JNJ-54861911 in Subjects who are Asymptomatic At Risk for Developi... not-yet-due
No trial status on register 2015-001042-28 Double-Blind, Randomized, Placebo-Controlled, Crossover Study Evaluating the Academic, Behavioral and Cognitive Effects of CONCERTA on Older Children with ADHD (The ABC Study) bad-data
No trial status on register 2015-001070-18 The Effective and Tolerable Titration Scheme and Dosage in Children with Attention-deficit hyperactivity disorder Treated with OROS-Methylphenidate bad-data
No trial status on register 2015-001081-26 The ABC Study: A Double-Blind, Randomized, Placebo-Controlled, Crossover Study Evaluating the Academic, Behavioral, and Cognitive Effects of CONCERTA on Older Children with ADHD bad-data
No trial status on register 2015-001084-39 Efficacy and learning skill after OROS Methylphenidate treatment in adolescents with Attention-Deficit/Hyperactivity Disorder: A 12-week, multi-center, open-label study bad-data
No trial status on register 2015-001216-35 From Immediate-release MPH to OROS MPH: The Impact Upon Family of Children and Adolescents With ADHD bad-data
No trial status on register 2015-001217-27 An Open-label Prospective Trial to Evaluate Functional Outcomes of OROS Methylphenidate in Children with ADHD (FOSCO) bad-data
No trial status on register 2015-001218-92 A prospective, open-labeled, multicenter study of optimal dosages of OROS-methylphenidate in treating children and adolescents with Attention-Deficit Hyperactivity Disorder bad-data
No trial status on register 2015-001219-11 A randomized double-blind (withdrawal) phase 3 study to evaluate the efficacy and tolerability of pancrelipase MT capsules compared with placebo in the treatment of subjects with cystic fibrosis-depen... bad-data
No trial status on register 2015-001220-31 Risperidone in the Treatment of Children and Adolescents With Autistic Disorder: A Double-Blind, Placebo-Controlled Study of Efficacy and Safety, Followed by an Open-Label Extension Study of Safety bad-data
No trial status on register 2015-001221-16 A Prospective Study of the Clinical Outcome Following Treatment Discontinuation After Remission in First-Episode Schizophrenia bad-data
No trial status on register 2015-001222-42 A double-blind trial comparing the efficacy, tolerability and safety of monotherapy topiramate versus phenytoin in subjects with seizures indicative of new onset epilepsy bad-data
No trial status on register 2015-001223-23 TOPAMAX (Topiramate) Initiated as Monotherapy in Epilepsy (TIME): A Multicenter, Outpatient, Open-Label, Study to Evaluate the Dosing, Effectiveness and Safety of TOPAMAX as Monotherapy in the Treatme... bad-data
No trial status on register 2015-001225-16 An Open-Label Study to Evaluate the Single-Dose Pharmacokinetics and Safety of Doripenem in Pediatric Subjects 6 to 17 Years of age, Inclusive, With Cystic Fibrosis bad-data
No trial status on register 2015-001226-42 An Open-Label, Single-Dose Study to Assess the Safety of 500-mg Mebendazole Chewable Formulation in Children 2 to 10 Years of Age, Inclusive bad-data
No trial status on register 2015-001320-31 A Double-blind, Placebo-controlled Study, Followed by an Open-label Extension Study Evaluating the Efficacy and Safety of Risperidone (R064766) in Children and Adolescents with Irritability Associated... bad-data
Ongoing 2015-001611-12 A Randomized Phase 2/3 Study of DACOGEN® (Decitabine) Plus JNJ-56022473 (Anti-CD123) Versus DACOGEN (Decitabine) Alone in Patients with AML who are not Candidates for Intensive Chemotherapy not-yet-due
Ongoing 2015-001630-21 Efficacy and Safety of Rivaroxaban Prophylaxis Compared with Placebo in Ambulatory Cancer Patients Initiating Systemic Cancer Therapy and at High Risk for Venous Thromboembolism not-yet-due
Reported results 2015-001672-22 A randomized, placebo-controlled, 2-way crossover, double-blind study to evaluate the efficacy, safety and tolerability of JNJ-42847922 in subjects with insomnia disorder without psychiatric comorbidi... 2015-12-02 due-trials
Listed as ongoing, but also has a completion date and reported results 2015-002003-28 A Phase 1b, randomized, partially double-blind, placebo-controlled study to assess the pharmacokinetics, safety, and tolerability of multiple doses of orally administered JNJ-53718678 in infants hospi... 2017-11-10 bad-data
Other 2015-002007-29 A Phase 2a Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multi-center Study Investigating the Efficacy, Safety, and Tolerability of JNJ-42165279 in Subjects with Major Depressive Disor... not-yet-due
Ongoing 2015-002610-76 A Prospective, Open-Label, Active-Controlled Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Rivaroxaban for Thromboprophylaxis in Pediatric Subjects 2 to 8 Years of ... not-yet-due
Ongoing 2015-002874-19 A Study to Evaluate Imetelstat (JNJ-63935937) in Transfusion-Dependent Subjects with IPSS Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) that is Relapsed/Refractory to Erythropoiesis-Stimul... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2015-002923-24 A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Prospective Study to Evaluate the Safety and Efficacy of Domperidone in 6-month-old to 12-year-old Pediatric Subjects With ... 2017-08-01 bad-data
Ongoing 2015-002993-19 An Open-Label Treatment Use Protocol for Daratumumab in Subjects with Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor and an Immunomodulatory Age... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2015-003002-17 A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir Adult and Elderly Hospita... 2017-03-15 bad-data
Ongoing 2015-003007-38 A Randomized, Double-blind, Placebo-controlled Phase 3 Study of JNJ-56021927 in Subjects with High-risk, Localized or Locally Advanced Prostate Cancer Receiving Treatment with Primary Radiation Therap... not-yet-due
Ongoing 2015-003578-34 An Open-label Long-term Extension Safety Study of Intranasal Esketamine in Treatment resistant Depression not-yet-due
Ongoing 2015-004139-11 A Multi-country, Prospective, Clinical Safety Study of Subjects Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo not-yet-due
Completed, report not yet due 2015-004200-38 A Phase 2b, Multicenter, Randomized, Open-label Study to investigate the Efficacy, Safety and Pharmacokinetics of Different Treatment Regimens of AL-335, Odalasvir, and Simeprevir in Treatment-naïve a... 2017-11-16 not-yet-due
Completed, report not yet due 2015-004835-10 A 52-Week, Open-Label, Prospective, Multicenter, International Study of a Transition to the Paliperidone Palmitate 3-Month Formulation In Patients with Schizophrenia Previously Stabilized on the Palip... 2018-03-26 not-yet-due
Ongoing 2015-005282-22 A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Adaptive Dose-Finding Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in... not-yet-due
Other 2016-000121-40 A Phase 3 Open-label Study to Assess the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric ... not-yet-due
Other 2016-000259-28 A Randomized, Open-label, Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Patients With Relapsed or Refractory Mature B-cell non-Hodgkin Lymphoma. not-yet-due
Ongoing 2016-000634-21 A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of JNJ-64304500 in Subjects with Moderately to Severely Active Crohn’... not-yet-due
No trial status on register 2016-000728-24 A Double-Blind, Randomized, Multi-Center, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Single Dose of a 500-mg Chewable Tablet of Mebendazole in the Treatment of S... bad-data
No trial status on register 2016-000929-40 A Randomized Controlled Study of YONDELIS (Trabectedin) or Dacarbazine for the Treatment of Advanced Liposarcoma or Leiomyosarcoma bad-data
Ongoing 2016-001163-37 A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Subjects with Active Psoriatic Arthritis incl... not-yet-due
Ongoing 2016-001205-16 A Phase 3 Randomized, Multicenter Study of Subcutaneous Daratumumab Versus Active Monitoring in Subjects with High-risk Smoldering Multiple Myeloma not-yet-due
Ongoing 2016-001224-63 A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Subjects with Active Psoriatic Arthritis not-yet-due
Reported results 2016-001267-36 PHARMACODYNAMIC EFFECTS OF NICOTINE MOUTH SPRAY AND CYTISINE TABLET. A STUDY IN HEALTHY SMOKERS. 2016-10-07 due-trials
Other 2016-001653-40 A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered ALS-008176 Regim... not-yet-due
Ongoing 2016-001737-27 A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Daratumumab in Combination with Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared With CyBorD Alone in Newly Diagnosed ... not-yet-due
Other 2016-001956-22 A Randomized Double-blind Pharmacokinetic study of Ustekinumab in Pediatric Subjects with Moderately to Severely Active Crohn's Disease not-yet-due
Ongoing 2016-002017-22 A First-in-Human, Open-label, Phase 1/2 Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Subjects with Adva... not-yet-due
Completed, report not yet due 2016-002022-37 A Phase 3, Multicenter, Randomized, Double-blind Placebo-controlled Study Evaluating the Efficacy and Safety of CNTO 1959 (Guselkumab) Delivered via a SelfDose™ Device in the Treatment of Subjects wit... 2018-02-06 not-yet-due
Other 2016-002057-38 A Phase 2 Efficacy and Safety Study of Niraparib in Men with Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies not-yet-due
Other 2016-002095-26 A Long-term Follow-up of Study 64041575RSV2004 to Evaluate the Impact of Lumicitabine (JNJ-64041575) on the Incidence of Asthma and/or Wheezing in Infants and Children with a History of Respiratory Sy... not-yet-due
Ongoing 2016-002135-15 Multicenter, randomized, open-label, efficacy assessor-blinded, active comparator-controlled phase 3b study to compare the efficacy of guselkumab to fumaric acid esters (Fumaderm® initial/ Fumaderm®) ... not-yet-due
Ongoing 2016-002543-41 An Open-label Randomized Phase 1b/2 Study of the Efficacy and Safety of JNJ-64041757, a Live Attenuated Listeria monocytogenes Immunotherapy, in Combination with Nivolumab Versus Nivolumab Monotherapy... not-yet-due
Other 2016-002579-83 A Phase 1b/2, Open-Label, Randomized Study of Daratumumab Administered in Combination with Atezolizumab Compared with Atezolizumab Alone in Subjects with Previously Treated Advanced or Metastatic Non-... not-yet-due
Completed, report not yet due 2016-002608-19 A Prospective 3-Year Follow-up Study in Subjects Treated in a Preceding Phase 2 or 3 Study With a Regimen Containing Odalasvir and AL-335 With or Without Simeprevir for the Treatment of Hepatitis C Vi... 2018-01-31 not-yet-due
Ongoing 2016-002918-43 Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn’s Disease Patients Treated with Ustekinumab not-yet-due
Ongoing 2016-002995-29 A Phase 3, Multicenter, Randomized, Double-blind Study Evaluating the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis not-yet-due
Other 2016-003328-22 A Phase 2 Proof-of-Concept Study to Separately Evaluate the Activity of Talacotuzumab (JNJ-56022473) or Daratumumab in Transfusion-Dependent Subjects with Low or Intermediate-1 Risk Myelodysplastic Sy... not-yet-due
Ongoing 2016-003990-17 A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms ... not-yet-due
Ongoing 2016-003992-23 A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms ... not-yet-due
Other 2016-004422-42 A Double-blind, Randomized, Psychoactive Placebo-controlled, Study to Evaluate the Efficacy and Safety of 3 Fixed Doses (28 mg, 56 mg and 84 mg) of Intranasal Esketamine in Addition to Comprehensive S... not-yet-due
Ongoing 2016-004550-15 A Randomized, Double-blind, Double-dummy, Multicenter, Adaptive Design Dose-Escalation (Part 1) and Dose-Response (Part 2) Study to Evaluate the Safety and Efficacy of Intravenous JNJ-64179375 Versus ... not-yet-due
Other 2016-005223-88 A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (≥10 to <18 years) with Type 2 Dia... not-yet-due
Ongoing 2017-000206-38 A Phase 3 Randomized, Multicenter Study of Subcutaneous vs. Intravenous not-yet-due
Ongoing 2017-000225-12 A Phase 1b Study to Evaluate SIMPONI® (golimumab) Therapy in Children, Adolescents and Young Adults with Pre-Symptomatic Type 1 Diabetes not-yet-due
No trial status on register 2017-000285-30 Continued access to darunavir/ritonavir (DRV/rtv) in HIV-1 infected adults, adolescents and children aged 3 years and above. bad-data
Ongoing 2017-000980-33 A Multicenter, Double-Blind, Randomized, Parallel-Group, Active- and Placebo-Controlled Polysomnography Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Subjects with Insomn... not-yet-due
Ongoing 2017-001110-29 A Phase 2a, Randomized, Partially-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Pharmacokinetics of 24 Weeks of Treatment With Multiple Doses of JNJ-56136379 as Monotherapy and i... not-yet-due
Ongoing 2017-001345-27 A Randomized, Double-blind, Phase 1/2a Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad26.RSV.preF in Adults 18 to 50 Years of Age and RSV-seropositive Toddlers 12 to 24 Months of A... not-yet-due
Other 2017-001489-53 A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Ustekinumab in Subjects with Active Systemic Lupus Erythematosus not-yet-due
Other 2017-001696-22 A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine (JN... not-yet-due
Other 2017-001862-56 A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine (JNJ... not-yet-due
Ongoing 2017-001941-28 A Double-blind, Randomized, Active-controlled, Parallel-group Study of Paliperidone Palmitate 6 Month Formulation. not-yet-due
Ongoing 2017-001980-19 A Phase 1b-2 Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Erdafitinib plus JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Subjects with Metastatic or Surgically Un... not-yet-due
Other 2017-002156-84 A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-care Treatment in Adolescent, Adult, and ... not-yet-due
Ongoing 2017-002195-13 A Phase 2/3, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Participants with Moderately to Severel... not-yet-due
Other 2017-002217-59 A Phase 3 Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-care Treatment in Adolescent, Adult, and... not-yet-due
Ongoing 2017-002611-34 A Randomized, Open-label, Multicenter, Multiphase Study of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, Administered in Combination with Daratumumab, Compared with Daratumumab Alone in Subjects wit... not-yet-due
Ongoing 2017-002932-18 A Phase 3 Study of Erdafitinib Compared with Vinflunine or Docetaxel or Pembrolizumab in Subjects with Advanced Urothelial Cancer and Selected FGFR Gene Aberrations not-yet-due
No trial status on register 2017-003053-42 A Phase 3, Multicenter, Randomized, Placebo- and Active Comparator-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics (PK) of Subcutaneously Administered Guselkumab for the Treatme... bad-data
Ongoing 2017-003252-24 A Pilot Phase 2a, Randomized, Double-blind, Placebo-controlled Study to Explore the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of JNJ- 53718678 at Two Dose Level... not-yet-due
Other 2017-003377-34 An Open-label, Multicenter, Phase 2 Study Evaluating the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Subjects ≥1 and ≤30 Years of Age With Relapsed/Refractory Precursor B-cell or T... not-yet-due
Ongoing 2017-003552-23 A Phase 1b-2 Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer not-yet-due
Ongoing 2017-003616-39 A Randomized, Double-blind Placebo-controlled and Open-label Active-controlled, Parallel-group, Multicenter, Dose-ranging Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Seve... not-yet-due
Ongoing 2017-004203-41 A Multicenter Phase 2 Study to Evaluate Subcutaneous Daratumumab in Combination with Standard Multiple Myeloma Treatment Regimens not-yet-due
Ongoing 2017-004209-41 A Phase 3b, Multicenter, Randomized, Blinded, Active-Controlled Study to Compare the Efficacy and Safety of Ustekinumab to that of Adalimumab in the Treatment of Biologic Naïve Subjects with Moderatel... not-yet-due
Ongoing 2017-004699-77 A Randomized, Open-label, Phase 3 study of the Combination of Ibrutinib plus Venetoclax versus Chlorambucil plus Obinutuzumab for the First-line Treatment of Subjects with Chronic Lymphocytic Leukemia... not-yet-due